MARKET

LXRX

LXRX

Lexicon Pharmaceuticals Inc
NASDAQ
1.630
+0.010
+0.62%
Closed 19:57 04/18 EDT
OPEN
1.670
PREV CLOSE
1.620
HIGH
1.730
LOW
1.620
VOLUME
3.72M
TURNOVER
0
52 WEEK HIGH
3.789
52 WEEK LOW
0.9200
MARKET CAP
401.37M
P/E (TTM)
-2.0350
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at LXRX last week (0408-0412)?
Weekly Report · 4d ago
Needham Sticks to Its Hold Rating for Lexicon Pharmaceuticals (LXRX)
TipRanks · 04/11 10:28
Needham Reiterates Hold on Lexicon Pharmaceuticals
Benzinga · 04/11 10:20
Weekly Report: what happened at LXRX last week (0401-0405)?
Weekly Report · 04/08 09:23
Weekly Report: what happened at LXRX last week (0325-0329)?
Weekly Report · 04/01 09:23
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday. The company issued preliminary fourth-quarter revenue outlook below estimates. MariaDB plc shares climbed 70.4%. Lixte Biotechnology Holdings, Inc. Shares jumped 68.6% in mid-day session.
Benzinga · 03/27 17:06
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
Shares of Cintas Corporation jumped 9.7% to $694.62 on Wednesday. The company reported better-than-expected third-quarter financial results and raised FY24 guidance. PaySign, Inc. Shares jumped 28.2% after the company announced better- than-expected fourth-quarter results. Dow Jones index gained around 300 points in Wednesday's session.
Benzinga · 03/27 14:03
WPRT, FIVN and FATE are among after hour movers
On the Move WPRT, FIVN and FATE are among after hour movers. Stoke Therapeutics (STOK) and AnaptysBio (ANAB) are among the Gainers. Westport Fuel Systems (WPRT) and Five9 (FIVN) are losers.
Seeking Alpha · 03/25 21:15
More
About LXRX
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The Company pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. The Company is conducting preclinical development of LX9851, an orally delivered small molecule drug candidate, as a treatment for obesity and tool for weight management.

Webull offers Lexicon Pharmaceuticals Inc stock information, including NASDAQ: LXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LXRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LXRX stock methods without spending real money on the virtual paper trading platform.